Working at the Sanger Institute is truly unique. We put collaboration, innovation and support for people as individuals at the centre of everything we do. Join us to help shape the future by delivering life-changing science with the reach, scale, and creativity to solve some of humanity’s greatest challenges.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We are committed to training the next generation of pioneering genome scientists and clinicians. At the Wellome Sanger Institute we give PhD students and postdocs all the tools they need to succeed in the field of genomics research.
Our vision and mission is to deliver world-leading genomics research in collaboration with research partners across the globe. Discover how our funding gives our leadership the independence to conduct bold, ambitious science that pioneers new fields in health, disease and conservation.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
By focusing on fundamental discovery research led by our faculty and employing our unique scale in cutting-edge data generation and analysis, we deliver discoveries not easily made elsewhere.
From providing fundamental resources for understanding biology to exploring cancer genomes and the effects of variation in human genomes, our work lays the foundations for personalised medicine. We also reveal the secrets of human development and how infectious diseases evolve and spread.
Discover how our leadership and structures are designed to enable holistic and effective decision making, with transparency and accountability woven into their make up.
The diversity in skills and knowledge that we all bring make our Institute the thriving ideas factory that it is. Discover how we support each other to reach our full potential and thrive. We celebrate diversity and seek to ensure that everyone has equal access to professional and career development opportunities.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We play a pivotal role in helping to shape Government and International research policies. We also lead the way in developing guidance to support our scientists to carry out their research ethically, equitably and responsibly.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We are sited on the Wellcome Genome Campus at the very heart of a global hub of fundamental and applied genomic research, education and engagement. It is home to some of the world’s foremost institutes and organisations using genomes and biodata to deliver science with the reach, scale and imagination to solve some of humanity’s greatest challenges and maximise societal benefit.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways.
We tackle some of the most difficult challenges in genomic research. This demands science at scale; a visionary and creative approach to research that pushes the boundaries of our understanding in ever new and exciting ways. Read more
Our research is organised into six primary Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. In addition, our Associate Research programmes pioneer new approaches to studying health and disease.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
The Sanger Institute has published papers in some of the most prestigious scientific journals. We aim to publish research that will transform biology and improve healthcare.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Sanger Institute’s Research Policies are designed to provide guidance to help researchers navigate the legislation relating to their research and to ensure that research is ethical and legal.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
The Sanger Institute played a major role in the genomic surveillance of the COVID-19 pandemic, providing large-scale high-throughput sequencing of the SARS-CoV-2 virus and analysis of its evolution and spread in the UK.
Throughout the COVID-19 lockdown of 2020-2021 we hosted a series of monthly freely available and open virtual seminars. From using genomic approaches to map all cell types in the human body, understand how cancer develops, and track the evolution and spread of global diseases, our senior scientists and faculty presented the latest developments in their field.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease or analytic focus. In all cases, the studies provide insights into human, pathogen, cellular evolution, the phenotypic and hence biological consequences of genome variation and the processes which cause mutations.
Our science is organised into six Scientific Programmes, each defining a major area of research with a particular biological, disease, analytic or generative focus. Read more
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
The Sanger Leadership Team is an Executive Committee that enables holistic and effective decision making, with transparency and accountability woven into its make up.
We draw on a number of experienced and internationally recognised scientists to provide independent scientific support, advice and challenge to help us maintain our scientific excellence.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
Our Faculty conceive and deliver our science. Within our strategic framework the Institute’s scientific aspirations are driven by their vision, imagination and intellectual energy.
Our Associate Faculty combine their skills and knowledge with the Sanger Institute’s unique abilities to conduct data generation and analysis at scale to pioneer genomic research in new areas.
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
From PhD students and Postdoctoral Fellows, bioinformaticians and laboratory managers, search for our staff who the support the delivery of pioneering science.
Almost 1,000 scientists, developers, engineers and skilled professionals work together to deliver the Sanger Institute’s cutting-edge genomic research.
Our science is founded on the talents, imagination and curiosity of our people. Our wet-lab scientists, bioinformaticians, developers, engineers and skilled administrators work together to deliver cutting-edge research. Join us Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Find out how our translation team maximises the socioeconomic impact of the Sanger Institute’s discoveries by translating our science into products, services and technologies that benefit patients in a variety of settings.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Read how we benefit society by buiding on the innovative capabilities of our people by engaging with businesses and creating commercial opportunities. We also develop a unique and vibrant ecosystem to establish and grow innovative genomics and biodata businesses.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
Read examples of how we engage with funding, R&D, service and clinical communities to promote real-world utilisation of the Sanger Institute’s technologies and resources.
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
We apply our science to benefit society by empowering innovators and engaging with businesses and investors - driven by Sanger Genomics Innovation Read more
The Communications team promote the Sanger Institute’s research and discoveries, using both traditional media such as print, radio interviews and TV footage and social media like Twitter, Facebook and the Sanger Institute blog
Ahead of this weekend’s HUGO meeting in Berlin, researchers from the Wellcome Trust Sanger Institute today (Thursday 1 April 2004) describe their studies of human chromosome 13 (published in Nature). Among the genes identified using the sequence of chromosome 13 are those that can dispose to breast cancer (BRCA2) as well as regions associated with schizophrenia and one containing a gene implicated in asthma.
One of the most remarkable results is just how few genes there are on chromosome 13 – although for the first time, researchers have used methods to predict the locations of a class of genes – so-called microRNA genes – which are important in controlling the activity of other genes.
The high-quality sequence consists of more than 95.5 million letters of DNA code. Painstaking study shows that, within that sequence, lie only 633 genes – fewer than on chromosome 22, which is less than half the size of 13.
“Chromosome 13 has a dramatic genomic landscape, in the centre of which is a huge ‘desert’ of only 47 genes. Normally we would expect about 180 genes in such a region of DNA.
“But what we have been able to do is look in greater detail at regions of the chromosome that may control gene activity. We have a clear image of regions that do not code for genes, but are shared with other species, and it is clear that some of these will encode regulatory messages.”
Andy Dunham Leader of the team at The Wellcome Trust Sanger Institute
Ruby Banerjee, Molecular Cytogenetics Group Sanger Institute, Genome Research Limited
Microscope image of human chromosomes, with a region of chromosome 13 (13q34) highlighted with fluorescent dye
So the wilderness of chromosome 13 has revealed a bounty of new and exciting detail. Recently developed tools and databases such as Rfam allowed the team to look deeper into regions that might previously have been thought to be barren – junk DNA.
MicroRNAs do not specify proteins, but bind to other RNAs and diminish their activity or even lead to their destruction. This is a level of control of genetic activity that was not widely recognized only two years ago. Today, several hundred genes for these RNAs are thought to be present in the human genome.
“Each chromosome brings its own surprises. Our genome is not a homogeneous whole, but a rich mixture of DNA sequences that are revealing new glimpses of how we control our genes and how our genome evolved to look the way it does. High-quality finished sequence and accurate gene analysis help us to pick apart the mysteries of what the large non-coding regions of our genome might do.”
Dr Jane Rogers Head of Sequencing at The Wellcome Trust Sanger Institute
Much remains to be uncovered: there are regions on chromosome 13 that appear to play an important role in leukaemias and lymphomas, but the genes involved have not been identified thus far. The sequence produced at the Sanger Institute can only speed that discovery.
More information
[Ruby Banerjee, Molecular Cytogenetics Group, Sanger Institute, Genome Research Limited
Microscope image of human chromosomes, with a region of chromosome 13 (13q34) highlighted with fluorescent dyeAbout 2-3% of the human genome codes for protein: much of the remainder is repetitive sequence, but some 40% or so is not. Some of this sequence will be important in gene regulation, but we are only just beginning to recognise where these regions may be and develop methods to study the roles that they play in controlling biological function. Comparing sequences of genomes from multiple species (comparative genomics) highlights regions that are conserved: these include genes and possible regulatory sequences.
Following the sequence of the human genome, new resources have been developed to help researchers investigate the range of genetic signals in genomes. Amongst these are ever-improving databases of RNA and protein families, which help the identification and description of novel genes – a process called annotation.
Recent results suggest that a class of small genes code for RNA molecules that are not translated into protein, but serve to control the activity of other genes. First clearly described in the worm C. elegans, so-called microRNAs (miRNAs) appear to act most commonly to reduce gene activity. It is only with sequence of entire genomes that this new and important class of molecules has been identified.
Chromosome 13 is acrocentric – that is the centromere (or ‘waist’) of the chromosome lies near one end, and the chromosome effectively has only one gene-coding arm. The sequence reported in the publication in Nature is some 95,564,076 base-pairs of DNA code, covering 98.3% of the long arm of chromosome 13. It consists of five sections.
The Wellcome Trust is the most diverse biomedical research charity in the world, spending about £450 million every year both in the UK and internationally to support and promote research that will improve the health of humans and animals. The Trust was established under the will of Sir Henry Wellcome, and is funded from a private endowment, which is managed with long-term stability and growth in mind. Websites: http://wellcome.org/ and Henry Wellcome
The Wellcome Trust Sanger Institute, which receives the majority of its funding from the Wellcome Trust, was founded in 1992. The Institute is responsible for the completion of the sequence of approximately one-third of the human genome as well as genomes of model organisms and more than 90 pathogen genomes. In October 2006, new funding was awarded by the